Ausgabe 10/2015
Inhalt (11 Artikel)
Radiation-induced camptocormia and dropped head syndrome
Clemens Seidel, Thomas Kuhnt, Rolf-Dieter Kortmann, Kathrin Hering
Early hematologic changes during prostate cancer radiotherapy predictive for late urinary and bowel toxicity
Michael Pinkawa, Carolina Ribbing, Victoria Djukic, Jens Klotz, Richard Holy, Michael J. Eble
Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland
Cédric M. Panje, Alan Dal Pra, Thomas Zilli, Daniel R. Zwahlen, Alexandros Papachristofilou, Fernanda G. Herrera, Oscar Matzinger, Ludwig Plasswilm, Paul Martin Putora
PSA bounce after 125I-brachytherapy for prostate cancer as a favorable prognosticator
Daniel S. Engeler, Christoph Schwab, Armin F. Thöni, Werner Hochreiter, Ladislav Prikler, Stefan Suter, Patrick Stucki, Johann Schiefer, Ludwig Plasswilm, Hans-Peter Schmid, Paul Martin Putora
Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy
Jose López-Torrecilla, Anna Boladeras, María Angeles Cabeza, Almudena Zapatero, Josep Jove, Luis M. Esteban, Ivan Henriquez, Manuel Casaña, Carmen González-San Segundo, Antonio Gómez-Caamaño, Jose Luis Mengual, Asunción Hervás, Julia Luisa Muñoz, Gerardo Sanz
Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy
Changhoon Song, Hyun-Cheol Kang, Jae-Sung Kim, Keun-Yong Eom, In Ah Kim, Jin-Beom Chung, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee
Dosimetrics of intracranial stereotactic radiosurgery
Alba Fiorentino, Niccolò Giaj-Levra, Rosario Mazzola, Sergio Fersino, Francesco Ricchetti, Filippo Alongi
Authors’ reply to “Dosimetric of intracranial stereotactic radiosurgery: only ‘an exercise of style’”
Harald Treuer, Moritz Hoevels, Klaus Luyken, Veerle Visser-Vandewalle, Jochen Wirths, Martin Kocher, Maximilian Ruge
Protonentherapie von Rhabdomyosarkompatienten im Kindesalter
Kristin Gurtner, Michael Baumann
Vergleich unterschiedlicher Fraktionsdosen bei der Einzeitbestrahlung schmerzhafter Knochenmetastasen
Carsten Nieder
TH-302 – ein neues unter Hypoxie aktiviertes Zytostatikum beim Pankreaskarzinom
Claudia Schmalz, Jürgen Dunst